Robuta

https://www.frontiersin.org/research-topics/17033/comparative-oncology---advances-in-veterinary-molecular-oncology/magazine Comparative Oncology - Advances in Veterinary Molecular Oncology | Frontiers Research Topic Molecular diagnostic assays are routinely performed in human oncology for the purpose of tumor classification, prognostication, identification of therapeutic... comparative oncologymolecular frontiersadvancesveterinaryresearch https://www.netapp.com/customers/european-institute-of-oncology/ European Institute of Oncology advances cancer treatment May 13, 2025 - Non-profit healthcare leader the European Institute of Oncology (IEO) relies on AI enablement to deliver powerful healthcare analytics and advance cancer... institute of oncologyeuropeanadvancescancertreatment https://www.miragenews.com/pfizer-unveils-oncology-advances-at-asco-2026-1660069/ Pfizer Unveils Oncology Advances at ASCO 2026 | Mirage News Pfizer Inc. (NYSE: PFE) will present new data across its diverse, industry-leading Oncology pipeline and portfolio at the American Society of Clinical oncology advancesasco 2026pfizerunveilsmirage https://www.spandidos-publications.com/or/24/4/829 Pathotropic targeting advances clinical oncology: Tumor-targeted localization of therapeutic gene... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. clinical oncologytargetingadvances https://www.nyp.org/advances/article/cancer/exceptional-expertise-in-rare-cancers Exceptional Expertise in Rare Cancers | Spotlight | Advances in Oncology | NewYork-Presbyterian At the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Irving Medical Center, researchers are at the forefront of... rare cancersexceptionalexpertisespotlightadvances https://www.businesswire.com/news/home/20260319962666/en/Agilent-Showcases-Advances-in-Precision-Oncology-and-Digital-Pathology-at-USCAP-2026 Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026 Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 Uni... precision oncology https://pmc.ncbi.nlm.nih.gov/articles/PMC12518345/ Advances in precision oncology using patient-derived organoids and functional biomaterials - PMC Despite major advances in oncology, cancer therapy continues to face persistent challenges due to intratumoral heterogeneity, drug resistance, and the poor... precision oncology https://www.nyp.org/newsletters/prof-adv/cancer/novel-perspectives-on-pancreatic-cancer Novel Perspectives on Pancreatic Cancer - Advances in Oncology | NewYork-Presbyterian Comprehensive medical and surgical oncology programs for pancreatic cancer at NYP complement exhaustive research underway by Columbia and Weill Cornell faculty... pancreatic cancernovelperspectivesadvancesoncology https://www.biospace.com/zielbio-appoints-alan-bash-ceo-as-company-advances-oncology-therapeutics ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics - BioSpace Jan 3, 2023 - ZielBio, Inc. has appointed Alan S. Bash as the company's new Chief Executive Officer and member of the company's Board of Directors. as companyappointsalanbashceo https://www.24-7pressrelease.com/press-release/534228/creative-biolabs-advances-oncology-frontiers-with-next-generation-synthetic-carbohydrate-based-cancer-vaccine-platforms Creative Biolabs Advances Oncology Frontiers with Next-Generation Synthetic Carbohydrate-Based... Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of... next generationcreativebiolabsadvancesoncology https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/research-advances Research Advances from the Oncology Models Forum (OMF) - NCI Mammalian models developed and validated through the Oncology Models Forum (OMF) have advanced preclinical and translational cancer research studies. research advancesfrom theoncology modelsforumomf https://www.nyp.org/advances/article/investigating-underlying-mechanisms-in-bladder-cancer Investigating Underlying Mechanisms in Bladder Cancer | Research | Advances in Oncology and Urology... A Columbia surgeon-scientist/urologic oncologist pursues translational research via patient-derived organoid lines to study the molecular profiles of... bladder cancerresearch advancesinvestigatingunderlyingmechanisms https://www.nyp.org/advances/article/pediatric-oncology/adolescent-and-young-adult-lymphoma-program Adolescent and Young Adult Lymphoma Program | Spotlight | Advances in Pediatric Oncology |... Our Adolescent and Young Adult Lymphoma program combines pediatric oncologists, medical oncologists, social workers, psychologists and fertility preservation... and youngprogram spotlightadolescentadultlymphoma https://www.news-medical.net/news/20240403/Advances-and-hurdles-The-impact-of-AI-on-oncology-care-efficiency-and-mortality-rates.aspx Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates Apr 3, 2024 - The benefits and limitations of precision medicine techniques in oncology research and treatment. the impact of ai https://oncupdates.com/ OncUpdates | Latest Oncology News & Cancer Treatment Advances Jun 15, 2026 - Stay informed with OncUpdates — your trusted source for the latest developments in oncology, cancer research, clinical guidelines, and treatment breakthroughs... oncology newscancer treatmentlatestadvances https://www.prnewswire.com/apac/news-releases/ipax-1-study-of-tlx101-investigational-glioblastoma-therapy-published-in-neuro-oncology-advances-302237287.html IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company's IPAX-1 Phase I study has been published in... https://www.marketscreener.com/news/lunit-presents-six-ai-studies-at-aacr-2026-highlighting-advances-in-precision-oncology-and-real-worl-ce7e50d3da8bf122 Lunit Presents Six AI Studies At AACR 2026 Highlighting Advances in Precision Oncology and... Apr 17, 2026 - Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor... https://audioboom.com/posts/8872176-unpacking-advances-across-radiation-oncology-from-asco-gu-2026 RadOnc on the Run / Unpacking Advances Across Radiation Oncology From ASCO GU 2026 Host Brandon Mancini, MD, MBA, FACRO, discusses presentations from ASCO GU 2026 featuring potential advances in the use of radiotherapeutic regimens. on the run https://www.wolterskluwer.com/zh-tw/solutions/ovid/therapeutic-advances-in-medical-oncology-17495 Ovid - Therapeutic Advances in Medical Oncology | Wolters Kluwer This open-access oncology journal is dedicated to publishing high-quality clinical research and clinically relevant translational studies that advance the... medical oncologyovidtherapeuticadvanceswolters https://www.nyp.org/advances/article/cancer/new-understanding-of-b-cell-cancers New Understanding of B-Cell Cancers | Research | Advances in Oncology | NewYork-Presbyterian Weill Cornell Medicine and Columbia University faculty at NewYork-Presbyterian Hospital have uncovered new information on the roles of the microenvironment and... b cell https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2022/10/12/18/09/Advances-in-Multimodality-Imaging Advances in Multimodality Imaging in Cardio-Oncology: Key Points - American College of Cardiology Salim Hayek, MD, FACC Share via: Print multimodality imagingcardio oncology https://www.finanznachrichten.de/nachrichten-2026-03/68023423-aethlon-medical-inc-advances-to-final-cohort-in-oncology-clinical-trial-following-positive-dsmb-review-008.htm Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB... SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon... https://www.nyp.org/advances/article/cancer/tumor-microenvironment-of-lung-cancer-what-lies-beneath Tumor Microenvironment of Lung Cancer: What Lies Beneath? | Research | Advances in Oncology |... Weill Cornell Medicine investigators examine the role of the tumor microenvironment in the progression of precancerous non-solid nodules that appear on CT to... what lies beneathtumor microenvironmentlung cancer https://www.uclahealth.org/departments/radonc/research-technologies/innovation-technology/external-beam-radiation-therapy-ebrt/stereotactic-body-radiation-therapy-sbrt/recent-treatment-advances Recent Treatment Advances - Radiation Oncology | UCLA Health Recent advances in radiation therapy are making it possible for us to move from two dimensional imaging to four dimensional and to provide more targeted... treatment advancesradiation oncologyrecentuclahealth https://www.tribuneindia.com/news/business/rgcon-2026-highlights-advances-in-neuro-oncology-as-india-faces-a-sharply-increasing-cancer-burden/ RGCON 2026 highlights advances in Neuro-Oncology as India faces a sharply increasing cancer burden... https://www.wolterskluwer.com/ko-kr/solutions/ovid/therapeutic-advances-in-medical-oncology-17495 Ovid - Therapeutic Advances in Medical Oncology | Wolters Kluwer This open-access oncology journal is dedicated to publishing high-quality clinical research and clinically relevant translational studies that advance the... medical oncologyovidtherapeuticadvanceswolters https://www.nyp.org/advances/article/novel-drug-regimen-shows-promise-for-early-stage-breast-cancer Novel Drug Regimen Shows Promise for Early-Stage Breast Cancer | Research | Advances in Oncology... The antibody-drug conjugate datopotamab deruxtecan in combination with the programmed cell death-ligand 1 inhibitor durvalumab was evaluated in the I-SPY 2.2...